WO2012169897A8 - Weight reducing material - Google Patents

Weight reducing material Download PDF

Info

Publication number
WO2012169897A8
WO2012169897A8 PCT/NO2012/000040 NO2012000040W WO2012169897A8 WO 2012169897 A8 WO2012169897 A8 WO 2012169897A8 NO 2012000040 W NO2012000040 W NO 2012000040W WO 2012169897 A8 WO2012169897 A8 WO 2012169897A8
Authority
WO
WIPO (PCT)
Prior art keywords
extract
disorders
prevent
effects
pains
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NO2012/000040
Other languages
French (fr)
Other versions
WO2012169897A1 (en
Inventor
Renate KIRCHNER
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RENATE KIRCHNER PRO HELSE
Original Assignee
RENATE KIRCHNER PRO HELSE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RENATE KIRCHNER PRO HELSE filed Critical RENATE KIRCHNER PRO HELSE
Priority to DE112012001971.7T priority Critical patent/DE112012001971T5/en
Publication of WO2012169897A1 publication Critical patent/WO2012169897A1/en
Publication of WO2012169897A8 publication Critical patent/WO2012169897A8/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Cardiology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Reproductive Health (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

An extract is described from the plant Filipendula ulmaria optionally containing Epilobium angustifolium, to reduce the weight or to prevent a weight increase of a mammal, including a human. The extract also reduces blood pressure and can be used to prevent and treat hypertension. The extract has also effects on secondary diseases such as lifestyle and stress diseases, depressions, muscular pains, skeletal pains, diabetes (in particular diabetes type II), heart and circulation disorders, fertility disorders, concentration and attention deficit disorders and fatty degeneration. Especially described are pain-relieving effects.
PCT/NO2012/000040 2011-05-04 2012-05-04 Weight reducing material Ceased WO2012169897A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE112012001971.7T DE112012001971T5 (en) 2011-05-04 2012-05-04 Weight reducing material

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO20110658A NO333173B1 (en) 2011-05-04 2011-05-04 Extract of Filipendula ulmaria.
NO2011658 2011-05-04

Publications (2)

Publication Number Publication Date
WO2012169897A1 WO2012169897A1 (en) 2012-12-13
WO2012169897A8 true WO2012169897A8 (en) 2013-11-21

Family

ID=47262807

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NO2012/000040 Ceased WO2012169897A1 (en) 2011-05-04 2012-05-04 Weight reducing material

Country Status (3)

Country Link
DE (1) DE112012001971T5 (en)
NO (1) NO333173B1 (en)
WO (1) WO2012169897A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1021980B1 (en) * 2014-05-20 2016-02-01 Dyna + Sarl SLIMMING COMPOSITION.
LU92458B1 (en) * 2014-05-20 2015-11-23 Dyna Sarl SLIMMING COMPOSITION
RU2726794C1 (en) * 2020-02-27 2020-07-15 Федеральное государственное бюджетное образовательное учреждение высшего образования "Самарский государственный медицинский университет" Министерства здравоохранения Российской Федерации Method for production of dense extract based on the meadowsweet fruits, having antidepressant activity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1008137A6 (en) * 1994-03-02 1996-01-30 Pirmez Th USE OF "LIERRE" IN PHYTO-ACTIVE COMPOSITIONS AIMED AT THE LOSS OF A LOCALIZED EXCESS OF FATTY TISSUE.
RU2108770C1 (en) * 1995-10-25 1998-04-20 Александр Иванович Суханов Method for treating spastic enterocolitis
RU2128054C1 (en) * 1996-01-30 1999-03-27 Бенчаров Юрий Владимирович Phytotherapeutic agent for an external use
RU2127106C1 (en) * 1998-03-16 1999-03-10 Суханов Александр Иванович Cholelithiasis treatment method
US5980905A (en) * 1998-08-28 1999-11-09 Ambi Inc. Chromium polynicotinate compositions and uses thereof
JP4233645B2 (en) * 1998-09-30 2009-03-04 御木本製薬株式会社 Lipase inhibitor
EP1238670A1 (en) * 2001-03-07 2002-09-11 Bruce Daniels Composition and method for treating and preventing cardiovascular disease and hypertension.
RU2199334C1 (en) * 2001-12-10 2003-02-27 Лосевской Владимир Петрович "praskovia" agent for treatment of patients with systemic vascular diseases of lower and upper limb (versions)
FR2839618B1 (en) * 2002-05-15 2004-07-16 Dominique Gagnant COMPOSITION OF MEDICINAL PLANTS FOR WEIGHT LOSS AND CELLULITE
JP4598740B2 (en) * 2006-09-22 2010-12-15 株式会社ファンケル Glutathione enhancing composition
FR2929120B1 (en) * 2008-03-28 2010-05-28 Nutraveris COMPOSITION HAVING BODY AND / OR DIURETIC SLIMMING ACTIVITY IN MAMMALS

Also Published As

Publication number Publication date
WO2012169897A1 (en) 2012-12-13
NO333173B1 (en) 2013-03-25
NO20110658A1 (en) 2012-11-05
DE112012001971T5 (en) 2014-02-06

Similar Documents

Publication Publication Date Title
PH12018500768A1 (en) Purin derivatives for use in the treatment of fab-related diseases
PE20150223A1 (en) ANTIBODIES ENHANCED ANTIBODIES AGAINST GROWTH AND DIFFERENTIATION FACTOR-8 AND THE USES OF THEM
EA201300558A1 (en) CONNECTIONS AND METHODS FOR MORNING PAIN
EA201390060A1 (en) ANNELED PYRIMIDINES AND TRIAZINES AND THEIR APPLICATION FOR THE TREATMENT AND / OR PREVENTION OF CARDIOVASCULAR DISEASES
EA201490546A1 (en) SUBSTITUTED ANNELED PYRIMIDINES AND THEIR APPLICATION
EA201291336A1 (en) SUBSTITUTED 5-FLUOR-1H-PYRAZOLOPIRIDINE AND THEIR APPLICATION
NZ702169A (en) The use of heat shock protein 90 (hsp90) modulators for the treatment of metabolic syndrome
WO2012083132A3 (en) Diagnosis and treatments relating to th2 inhibition
MX2011007397A (en) Dpp-iv inhibitors for treatment of diabetes in paediatric patients.
MX2019005130A (en) Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin.
BR112013030166A2 (en) method of differentiating pluripotent stem cells into vascular bed cells, endothelial cells or vascular soft muscle cells, biological banking and use of endothelial cells or vascular soft muscle cells, therapeutic composition, methods and uses.
WO2013169864A3 (en) TETRAHYDRO[1,8]NAPHTHYRIDINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORƴ AND THE TREATMENT OF DISEASE
WO2013013025A3 (en) Anti-cxcr4 antibodies and methods of use
EP2608797A4 (en) CD271 PRECURSOR CELLS FROM BONE MARROW FOR CARDIAC REPAIR
MX365007B (en) USE OF LYSOSOMAL LIPASE ACID TO TREAT LYSOSOMAL ACID LIPASE DIFFICIENCY IN PATIENTS.
WO2012047951A3 (en) Human lung stem cells and uses thereof
PH12014500301A1 (en) Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
EP2626071A4 (en) Applications of arctigenin in formulating medicines for preventing or treating diseases related to red blood cell reduction
WO2013126590A3 (en) Pharmaceutical composition comprising cd34+ cells
EA201591522A1 (en) TREATMENT OF THE TRANSPLANTATE REACTIONS AGAINST THE OWNER OF THE EXPOSED PATIENT TRANSPLANTATION
WO2017011356A3 (en) Mcj inhibitors for use in treating drug-induced diseases and conditions
BR112016028561A2 (en) composition, dosage form, and methods for reducing the risk for mortality in an individual, the risk for a disease or condition in an individual, triglycerides in an individual's blood, an individual's resting heart rate, lipoprotein cholesterol non-high density in an individual, total cholesterol in an individual, apolipoprotein b in an individual blood, systolic blood pressure in an individual, and diastolic blood pressure in an individual, to prolong an individual's life, to treat hypertriglyceridemia in an individual and to increase an omega-3 index in an individual's red blood cells.
WO2012169897A8 (en) Weight reducing material
EA201200838A1 (en) MEANS FOR TREATING PARKINSON'S DISEASE
NZ702666A (en) A method of weight reduction

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12797563

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 1120120019717

Country of ref document: DE

Ref document number: 112012001971

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12797563

Country of ref document: EP

Kind code of ref document: A1